TargetMol

1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil

Product Code:
 
TAR-TNU0014
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TNU0014-100mg100mg£99.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TNU0014-500mg500mg£142.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil is a purine nucleoside analog with a broad spectrum of antitumor activity targeting inert lymphoid malignancies and inducing apoptosis.1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil is a purine nucleoside analog that exhibits a broad spectrum of antitumor activity targeting inert lymphoid malignancies. The anticancer mechanism of 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil is dependent on the inhibition of DNA synthesis.
CAS:
69123-94-0
Formula:
C9H11FN2O5
Molecular Weight:
246.19
Pathway:
Apoptosis
Purity:
0.98
SMILES:
F[C@@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)NC(=O)C=C2
Target:
Apoptosis

References

Robak T, et al. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.